Literature DB >> 888257

Fifteen year review of treated cases of retinal angiomatosis.

W H Annesley, B C Leonard, J A Shields, W S Tasman.   

Abstract

This study describes the experience of the Wills Eye Hospital Retina Service in the treatment of 125 eyes with retinal angiomatosis, with follow-up ranging from 1 to 15 years. The results of several treatment modalities are compared. In lesions smaller than 2.5 DD, xenon arc photocoagulation, argon laser photocoagulation, and cryotherapy all appear to be effective in eradicating the tumor and salvaging useful visual acuity. For lesions larger than 2.5 DD, cryotherapy appeared to offer the best results. The advantages and disadvantages of the various treatment modalities are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 888257

Source DB:  PubMed          Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol        ISSN: 0161-6978


  15 in total

1.  Upregulation of hypoxia-inducible factors and autophagy in von Hippel-Lindau-associated retinal hemangioblastoma.

Authors:  Yujuan Wang; Mones S Abu-Asab; Defen Shen; Zhengping Zhuang; Emily Y Chew; Chi-Chao Chan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-24       Impact factor: 3.117

Review 2.  [Retinal angiomatosis. Ocular manifestation of von Hippel-Lindau disease].

Authors:  B Junker; D Schmidt; H T Agostini
Journal:  Ophthalmologe       Date:  2007-02       Impact factor: 1.059

3.  Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations.

Authors:  Emily Ying Chew
Journal:  Trans Am Ophthalmol Soc       Date:  2005

4.  Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis.

Authors:  Wai T Wong; Elvira Agrón; Hanna R Coleman; George F Reed; Karl Csaky; James Peterson; Gladys Glenn; W Marston Linehan; Paul Albert; Emily Y Chew
Journal:  Arch Ophthalmol       Date:  2007-02

Review 5.  MANAGEMENT OF RETINAL HEMANGIOBLASTOMA IN VON HIPPEL-LINDAU DISEASE.

Authors:  Henry E Wiley; Valerie Krivosic; Alain Gaudric; Michael B Gorin; Carol Shields; Jerry Shields; Mary E Aronow; Emily Y Chew
Journal:  Retina       Date:  2019-12       Impact factor: 4.256

6.  Verteporfin photodynamic therapy of retinal capillary hemangioblastoma in von Hippel-Lindau disease.

Authors:  Harsha Bhattacharjee; Hemalata Deka; Satyen Deka; Manab Jyoti Barman; Mrinal Mazumdar; Jnanankar Medhi
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

7.  Classification and management of hereditary retinal angiomas.

Authors:  J J Augsburger; J A Shields; R E Goldberg
Journal:  Int Ophthalmol       Date:  1981-08       Impact factor: 2.031

8.  Intravitreal bevacizumab and feeder vessel laser treatment for a posteriorly located retinal capillary hemangioma.

Authors:  Aniruddha Agarwal; Neha Kumari; Ramandeep Singh
Journal:  Int Ophthalmol       Date:  2016-01-27       Impact factor: 2.031

9.  Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease.

Authors:  Wai T Wong; Elvira Agrón; Hanna R Coleman; Tam Tran; George F Reed; Karl Csaky; Emily Y Chew
Journal:  Ophthalmology       Date:  2007-06-01       Impact factor: 12.079

10.  Internal en bloc resection and genetic analysis of retinal capillary hemangioblastoma.

Authors:  Thomas Schlesinger; Binoy Appukuttan; Thomas Hwang; La-Ongsri Atchaneeyakasul; Chi-Chao Chan; Zhengping Zhuang; J Timothy Stout; David J Wilson
Journal:  Arch Ophthalmol       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.